相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SCN4B-encoded sodium channel β4 subunit in congenital long-QT syndrome
Argelia Medeiros-Domingo et al.
CIRCULATION (2007)
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: Effects of ranolazine
Serge Sicouri et al.
HEART RHYTHM (2007)
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: A CATIE study
T. Scott Stroup et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Novel mechanism for sudden infant death syndrome: Persistent late sodium current secondary to mutations in caveolin-3
Lisa B. Cronk et al.
HEART RHYTHM (2007)
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-Segment elevation, short QT intervals, and sudden cardiac death
Charles Antzelevitch et al.
CIRCULATION (2007)
Untitled - Response
Ruben Coronel et al.
HEART RHYTHM (2007)
Brugada electrocardiographic pattern due to tricyclic antidepressant overdose
M Akhtar et al.
JOURNAL OF ELECTROCARDIOLOGY (2006)
Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome
JM Fish et al.
CIRCULATION (2006)
Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7)
M Tsuboi et al.
HEART RHYTHM (2006)
Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction
CR Bezzina et al.
CIRCULATION (2006)
Long QT syndrome: reduced repolarization reserve and the genetic link
DM Roden
JOURNAL OF INTERNAL MEDICINE (2006)
Rote of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes
C Antzelevitch
HEART RHYTHM (2005)
Unmasking of Brugada syndrome by lithium
D Darbar et al.
CIRCULATION (2005)
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome
L Crotti et al.
CIRCULATION (2005)
Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest
R Liperoti et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Brugada syndrome - Report of the second consensus conference - Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
C Antzelevitch et al.
CIRCULATION (2005)
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome
PJ Schwartz et al.
CIRCULATION (2004)
Delay in right ventricular activation contributes to Brugada syndrome
R Tukkie et al.
CIRCULATION (2004)
Drug therapy: Drug-induced prolongation of the QT interval
DM Roden
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tricyclic antidepressants, QT interval prolongation, and Torsade de Pointes
WVR Vieweg et al.
PSYCHOSOMATICS (2004)
Role of sodium and calcium channel block in unmasking the Brugada syndrome
JM Fish et al.
HEART RHYTHM (2004)
Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels
BD Anson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Assessing predictors of drug-induced torsade de pointes
L Belardinelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Antipsychotic drugs and QT interval prolongation
W Zareba et al.
PSYCHIATRIC QUARTERLY (2003)
Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG)
KJ Paavonen et al.
CARDIOVASCULAR RESEARCH (2003)
Ventricular repolarization components on the electrocardiogram - Cellular basis and clinical significance
GX Yan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization
CR Bezzina et al.
CARDIOVASCULAR RESEARCH (2003)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
PJ Mohler et al.
NATURE (2003)
Psychotropic drugs, cardiac arrhythmia, and sudden death
HJ Witchel et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
LH Curtis et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia
T Araki et al.
CIRCULATION JOURNAL (2003)
Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome
A Nogami et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes
JM Fish et al.
JOURNAL OF ELECTROCARDIOLOGY (2003)
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data
S Hennessy et al.
BRITISH MEDICAL JOURNAL (2002)
Proposed diagnostic criteria for the Brugada syndrome - Consensus report
AAM Wilde et al.
CIRCULATION (2002)
Proposed diagnostic criteria for the Brugada syndrome
AAM Wilde et al.
EUROPEAN HEART JOURNAL (2002)
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia
I Splawski et al.
SCIENCE (2002)
The electrophysiologic ST-segment elevation mechanism of in Brugada syndrome
T Kurita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Overdose of cyclic antidepressants and the Brugada syndrome
D Goldgran-Toledano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Ionic current basis of electrocardiographic waveforms - A model study
K Gima et al.
CIRCULATION RESEARCH (2002)
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
P Yang et al.
CIRCULATION (2002)
Clinical and molecular heterogeneity in the Brugada syndrome - A novel gene locus on chromosome 3
R Weiss et al.
CIRCULATION (2002)
The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels
D Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Cellular mechanisms underlying the long QT syndrome
C Antzelevitch et al.
CURRENT OPINION IN CARDIOLOGY (2002)
Clozapine and sudden death
H Tie et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Antipsychotics and the risk of sudden cardiac death
WA Ray et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death
AH Glassman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Electrical heterogeneity within the ventricular wall
C Antzelevitch et al.
BASIC RESEARCH IN CARDIOLOGY (2001)
Asymptomatic Brugada Syndrome case unmasked during dimenhydrinate infusion
A Pastor et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion
J Ortega-Carnicer et al.
JOURNAL OF ELECTROCARDIOLOGY (2001)
Doxepin-induced torsade de pointes tachycardia
P Alter et al.
ANNALS OF INTERNAL MEDICINE (2001)
Heterogeneity of cellular repolarization in LQTS: the role of M cells
C Antzelevitch
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome
NM Plaster et al.
CELL (2001)
Pharmacogenetics and drug-induced arrhythmias
DM Roden
CARDIOVASCULAR RESEARCH (2001)
Brugada syndrome mimicked by tricyclic antidepressant overdose
H Tada et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
Transient ST segment elevation in right precordial leads induced by psychotropic drugs: Relationship to the Brugada syndrome
F Rouleau et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
Enhanced Ca2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes -: Potential link between contractile adaptation and arrhythmogenesis
KR Sipido et al.
CIRCULATION (2000)
Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome
W Shimizu et al.
CIRCULATION (2000)
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system
GA Ford et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
C Napolitano et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2000)
The heart of psychotropic drug therapy
H Tie et al.
LANCET (2000)
Drug-induced torsade de pointes: From molecular biology to bedside
J Tamargo
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline
ST Dorsey et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2000)
Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline
SH Jo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
AJ Moss et al.
CIRCULATION (2000)
Sodium channel blockers identify risk for sudden death in patients with ST-Segment elevation and right bundle branch block but structurally normal hearts
R Brugada et al.
CIRCULATION (2000)
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
W Shimizu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
